Cannabis-based multiple sclerosis drug approved in Wales but could be blocked in England - Telegraph

Cannabis-based Sativex treatment for MS set for UK approval
Sativex, a mouth spray derived from the cannabis plant, relieves muscle spasms in multiple sclerosis Photo: PA

GW Pharmaceuticals' cannabis-based multiple sclerosis drug Sativex will be made widely available in Wales, but could still be blocked in England.

The Welsh medicines board on Friday confirmed it had recommended Sativex to relieve muscle spasms in multiple sclerosis, as first reported in the Telegraph earlier this week.

Dr Sajida Javaid, a consultant in rehabilitation medicine at Neath Port Talbot Hospital hailed the Welsh recommendation as a "significant milestone for the treatment of spasticity".


Sativex was first launched in the UK in 2010, but patients have only

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.